Industry News
Sonic Hedgehog protein causes DNA damage and the development child brain tumors
Oct 15, 2014
Scientists at the IRCM and the University of Montreal discovered a mechanism that promotes the progression of medulloblastoma, the most common brain tumour found in children. Read More
Researchers find RNA molecules in urine and tissue that detect prostate cancer
Oct 14, 2014
Researchers at Sanford-Burnham Medical Research Institute have identified a set of RNA molecules that are detectable in tissue samples and urine of prostate cancer patients but not in normal... Read More
New cancer drug to begin trials in multiple myeloma patients
Oct 14, 2014
Scientists at Imperial College London have developed a new cancer drug which they plan to trial in multiple myeloma patients by the end of next year. Read More
Breast cancer: follow-up crucial for women after treatment
Oct 14, 2014
With Australian breast cancer survival rates at an all-time high, Cancer Australia's Pink Ribbon Breakfast focused on the importance of follow-up care to ensure the 15,000 women diagnosed this year... Read More
Mechanism that repairs brain after stroke discovered
Oct 14, 2014
A previously unknown mechanism through which the brain produces new nerve cells after a stroke has been discovered at Lund University and Karolinska Institutet in Sweden. Read More
Hormone loss could be involved in colon cancer
Oct 14, 2014
Some cancers, like breast and prostate cancer, are driven by hormones such as estrogen and testosterone, but to date, there are none that are driven by the lack of a hormone. Read More
Researchers find RNA molecules in urine and tissue that detect prostate cancer
Oct 14, 2014
Researchers at Sanford-Burnham Medical Research Institute have identified a set of RNA molecules that are detectable in tissue samples and urine of prostate cancer patients but not in normal... Read More
FDA approves Akynzeo for nausea and vomiting associated with cancer chemotherapy
Oct 14, 2014
The U.S. Food and Drug Administration has approved Akynzeo (netupitant and palonosetron) to treat nausea and vomiting in patients undergoing cancer chemotherapy. Read More
An unexpected bonus - blocking STAT3 could help cancer patients in two ways
Oct 14, 2014
The STAT transcription factors are involved in the development of many forms of cancer. STAT3 is frequently activated in tumour cells, so drugs targeting STAT3 could be used in cancer therapy. Read More
New cancer drug to begin trials in multiple myeloma patients
Oct 14, 2014
Scientists at Imperial College London have developed a new cancer drug which they plan to trial in multiple myeloma patients by the end of next year. Read More
Previous Page Next Page